Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3026% below fair value
$17.46+0.66 (+3.93%)
Close on Nov 20, 2026Market cap $1.21BP/E –Yield –
Tandem Diabetes Care free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Tandem Diabetes Care's free cash flow for the twelve months ending Jun 30, 2026 was -$26.62M. For fiscal 2025 it was -$29.67M, down 694.1% from the year before. The highest annual figure on record is $97.18M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.67M | -694.1% |
| FY2024 | Dec 31, 2024 | $4.99M | – |
| FY2023 | Dec 31, 2023 | -$58.61M | -458.1% |
| FY2022 | Dec 31, 2022 | $16.37M | -83.2% |
| FY2021 | Dec 31, 2021 | $97.18M | – |
| FY2020 | Dec 31, 2020 | -$2.74M | -112.2% |
| FY2019 | Dec 31, 2019 | $22.37M | – |
| FY2018 | Dec 31, 2018 | -$11.31M | – |
| FY2017 | Dec 31, 2017 | -$71.85M | – |
| FY2016 | Dec 31, 2016 | -$70.10M | – |
| FY2015 | Dec 31, 2015 | -$64.53M | – |
| FY2014 | Dec 31, 2014 | -$65.78M | – |
| FY2013 | Dec 31, 2013 | -$51.77M | – |
| FY2012 | Dec 31, 2012 | -$38.00M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$38.68M | – |
| Q1 FY2026 | Mar 31, 2026 | $4.79M | – |
| Q4 FY2025 | Dec 31, 2025 | $3.10M | -59.4% |
| Q3 FY2025 | Sep 30, 2025 | $4.17M | -80.6% |
| Q2 FY2025 | Jun 30, 2025 | -$15.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$21.24M | – |
| Q4 FY2024 | Dec 31, 2024 | $7.65M | – |
| Q3 FY2024 | Sep 30, 2024 | $21.54M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.74M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.42M | -6532.6% |
| Q3 FY2023 | Sep 30, 2023 | -$5.35M | -152.2% |
| Q2 FY2023 | Jun 30, 2023 | -$13.70M | – |
| Q1 FY2023 | Mar 31, 2023 | -$27.15M | -343.4% |
| Q4 FY2022 | Dec 31, 2022 | $193.00K | -98.6% |
| Q3 FY2022 | Sep 30, 2022 | $10.23M | -67.0% |
| Q2 FY2022 | Jun 30, 2022 | -$5.22M | -119.3% |
| Q1 FY2022 | Mar 31, 2022 | $11.16M | -55.7% |
| Q4 FY2021 | Dec 31, 2021 | $13.89M | +24.7% |
| Q3 FY2021 | Sep 30, 2021 | $31.05M | +297.9% |
| Q2 FY2021 | Jun 30, 2021 | $27.08M | +374.0% |
| Q1 FY2021 | Mar 31, 2021 | $25.16M | – |
| Q4 FY2020 | Dec 31, 2020 | $11.14M | -12.2% |
| Q3 FY2020 | Sep 30, 2020 | $7.80M | -57.6% |
| Q2 FY2020 | Jun 30, 2020 | $5.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$27.40M | – |
| Q4 FY2019 | Dec 31, 2019 | $12.69M | -4.2% |
| Q3 FY2019 | Sep 30, 2019 | $18.40M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.19M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.53M | – |
| Q4 FY2018 | Dec 31, 2018 | $13.25M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.47M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.30M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.79M | – |
| Q4 FY2017 | Dec 31, 2017 | -$13.06M | – |
| Q3 FY2017 | Sep 30, 2017 | -$19.26M | – |
| Q2 FY2017 | Jun 30, 2017 | -$16.08M | – |
| Q1 FY2017 | Mar 31, 2017 | -$23.46M | – |
| Q4 FY2016 | Dec 31, 2016 | -$16.33M | – |
| Q3 FY2016 | Sep 30, 2016 | -$20.29M | – |
See a number that looks wrong?